Yonghui Dong

796 total citations
21 papers, 577 citations indexed

About

Yonghui Dong is a scholar working on Molecular Biology, Pharmacology and Oncology. According to data from OpenAlex, Yonghui Dong has authored 21 papers receiving a total of 577 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 6 papers in Pharmacology and 5 papers in Oncology. Recurrent topics in Yonghui Dong's work include Bone Metabolism and Diseases (6 papers), Bone health and treatments (5 papers) and Inflammatory mediators and NSAID effects (4 papers). Yonghui Dong is often cited by papers focused on Bone Metabolism and Diseases (6 papers), Bone health and treatments (5 papers) and Inflammatory mediators and NSAID effects (4 papers). Yonghui Dong collaborates with scholars based in China, United Kingdom and Australia. Yonghui Dong's co-authors include Anmin Chen, Peng Cheng, Yuting Wang, Hui Huang, Hui Liu, Yutong Gao, Zhipeng Du, Fei Xu, Fengjing Guo and Shilong Huang and has published in prestigious journals such as Journal of Agricultural and Food Chemistry, The FASEB Journal and International Journal of Molecular Sciences.

In The Last Decade

Yonghui Dong

19 papers receiving 571 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yonghui Dong China 12 335 153 134 72 62 21 577
Yoon‐Hee Cheon South Korea 16 407 1.2× 103 0.7× 153 1.1× 87 1.2× 58 0.9× 36 558
Yuangang Su China 14 391 1.2× 75 0.5× 162 1.2× 99 1.4× 44 0.7× 40 517
Xiaoying Zhao China 13 245 0.7× 108 0.7× 86 0.6× 38 0.5× 37 0.6× 35 501
Myeung Su Lee South Korea 16 539 1.6× 112 0.7× 243 1.8× 96 1.3× 121 2.0× 31 778
Nianhu Li China 10 248 0.7× 67 0.4× 49 0.4× 55 0.8× 61 1.0× 34 417
Myung-Soon Sung South Korea 7 212 0.6× 71 0.5× 56 0.4× 22 0.3× 109 1.8× 7 432
Ji‐Yoon Noh South Korea 13 308 0.9× 44 0.3× 128 1.0× 71 1.0× 20 0.3× 19 558

Countries citing papers authored by Yonghui Dong

Since Specialization
Citations

This map shows the geographic impact of Yonghui Dong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yonghui Dong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yonghui Dong more than expected).

Fields of papers citing papers by Yonghui Dong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yonghui Dong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yonghui Dong. The network helps show where Yonghui Dong may publish in the future.

Co-authorship network of co-authors of Yonghui Dong

This figure shows the co-authorship network connecting the top 25 collaborators of Yonghui Dong. A scholar is included among the top collaborators of Yonghui Dong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yonghui Dong. Yonghui Dong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Jia, Yonghui Dong, Yunlong Li, et al.. (2025). Protocatechuic Acid Suppresses Lipid Uptake and Synthesis through the PPARγ Pathway in High-Fat Diet-Induced NAFLD Mice. Journal of Agricultural and Food Chemistry. 73(7). 4012–4026. 3 indexed citations
2.
3.
Dong, Yonghui, Xue Wu, Jie Li, et al.. (2025). Phloretin Suppresses the mPTP Abnormal Opening via the SHP-2/JAK2/BAX Axis to Ameliorate Nonalcoholic Steatohepatitis. Journal of Agricultural and Food Chemistry. 73(42). 26700–26713.
4.
Wang, Yaocen, Yonghui Dong, Qingwei Li, et al.. (2023). A complete prostaglandin pathway from synthesis to inactivation in the oral gland of the jawless vertebrate lamprey, Lethenteron camtschaticum. Developmental & Comparative Immunology. 148. 104903–104903. 2 indexed citations
5.
Dong, Yonghui, Ping Wang, Yong‐Guang Yang, et al.. (2020). PRMT5 inhibition attenuates cartilage degradation by reducing MAPK and NF-κB signaling. Arthritis Research & Therapy. 22(1). 201–201. 20 indexed citations
6.
Liu, Hui, Yonghui Dong, Yutong Gao, et al.. (2018). Hesperetin suppresses RANKL‐induced osteoclastogenesis and ameliorates lipopolysaccharide‐induced bone loss. Journal of Cellular Physiology. 234(7). 11009–11022. 38 indexed citations
7.
Liang, Shuang, Zheng‐tao Lv, Jiaming Zhang, et al.. (2018). Necrostatin-1 Attenuates Trauma-Induced Mouse Osteoarthritis and IL-1β Induced Apoptosis via HMGB1/TLR4/SDF-1 in Primary Mouse Chondrocytes. Frontiers in Pharmacology. 9. 1378–1378. 55 indexed citations
8.
Wang, Shengjie, Jie Li, Jiwei Tian, et al.. (2018). High amplitude and low frequency cyclic mechanical strain promotes degeneration of human nucleus pulposus cells via the NF‐κB p65 pathway. Journal of Cellular Physiology. 233(9). 7206–7216. 20 indexed citations
9.
Xiang, Wei, Jiaming Zhang, Rui Wang, et al.. (2018). Role of IFT88 in icariin‑regulated maintenance of the chondrocyte phenotype. Molecular Medicine Reports. 17(4). 4999–5006. 8 indexed citations
10.
Song, Chao, Zheng Zhang, Wei Wu, et al.. (2018). REV‐ERB agonism suppresses osteoclastogenesis and prevents ovariectomy‐induced bone loss partially via FABP4 upregulation. The FASEB Journal. 32(6). 3215–3228. 33 indexed citations
11.
Dong, Yonghui, Chao Song, Yuting Wang, et al.. (2017). Inhibition of PRMT5 suppresses osteoclast differentiation and partially protects against ovariectomy-induced bone loss through downregulation of CXCL10 and RSAD2. Cellular Signalling. 34. 55–65. 49 indexed citations
12.
Liu, Hui, Yutong Gao, Yonghui Dong, et al.. (2017). Flavonoids Active Against Osteosarcoma: A Review of the Molecular Mechanisms Involved. Current Pharmaceutical Design. 23(13). 1993–2001. 21 indexed citations
13.
Xu, Fei, Yonghui Dong, Xin Huang, et al.. (2016). Pioglitazone affects the OPG/RANKL/RANK system and increase osteoclastogenesis. Molecular Medicine Reports. 14(3). 2289–2296. 19 indexed citations
14.
Liu, Hui, Yonghui Dong, Yutong Gao, et al.. (2016). The Fascinating Effects of Baicalein on Cancer: A Review. International Journal of Molecular Sciences. 17(10). 1681–1681. 198 indexed citations
15.
Wang, Yuting, Yonghui Dong, Chao Song, et al.. (2016). Downregulation of FABP4 promotes osteoclast formation and function by acting PPAR-γ signaling. Journal of Orthopaedic Translation. 7. 128–128. 1 indexed citations
16.
Huang, Xin, Shilong Huang, Fei Xu, et al.. (2015). Dose-dependent inhibitory effects of zoledronic acid on osteoblast viability and function in vitro. Molecular Medicine Reports. 13(1). 613–622. 54 indexed citations
17.
Cheng, Peng, Xuying Sun, Fei Xu, et al.. (2015). Nanog down-regulates the Wnt signaling pathway via β-catenin phosphorylation during epidermal stem cell proliferation and differentiation. Cell & Bioscience. 5(1). 5–5. 9 indexed citations
18.
Xu, Fei, Yonghui Dong, Xin Huang, et al.. (2014). Decreased osteoclastogenesis, osteoblastogenesis and low bone mass in a mouse model of type 2 diabetes. Molecular Medicine Reports. 10(4). 1935–1941. 17 indexed citations
19.
Xu, Fei, Yaping Ye, Yonghui Dong, et al.. (2013). Inhibitory effects of high glucose/insulin environment on osteoclast formation and resorption in vitro. Journal of Huazhong University of Science and Technology [Medical Sciences]. 33(2). 244–249. 28 indexed citations
20.
Cao, Jinxiang, et al.. (1998). Analyzing Characters of Plasma Wake with Method of Chaos Dynamics. Chinese Physics Letters. 15(12). 889–891. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026